• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PEM
Click for more information
0.00% 35.0¢

PERILYA LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PEM
Ann: Perilya Announces Implementation of Scheme o 		29/12/13 4 2.9K
29/12/13 Last post  HTG1971 Comments Created with Sketch.  4  Views Created with Sketch.  2.9K 
PEM
Ann: Removal from close of trading 19 December 20 		18/12/13 0 688
18/12/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  688 
PEM
Ann: Change of Director's Interest Notice - M 		13:36 0 634
13:36 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  634 
PEM
Ann: Change of Director's Interest Notice - P 		13:34 0 664
13:34 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  664 
PEM
Ann: Appendix 3B - Vesting of Performance Rights 		13:33 0 723
13:33 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  723 
PEM
what happened? 		11:22 0 811
11:22 Last post  williak Comments Created with Sketch.  0  Views Created with Sketch.  811 
PEM
Ann: ASX Circular - Scheme of Arrangement 		09/12/13 0 490
09/12/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  490 

See All Discussions arrow Created with Sketch.

Top Stories

Cyclone signs MOU with Vale for development of Iron Bear play

Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.